Advances in PH Journal
Advances in Pulmonary Hypertension Autumn 2008 (Vol 7, No 3)
- Editor's Memo
A few years after I began to work in the field of PH with my mentor, Dr. Bruce Brundage, I missed what would have been my 1st International PHA conference in 1998: my son was born 2 days before the meeting started. At the time I did not know what I would be missing.
- Guest Editor's Memo
From PHA's Scientific Sessions, a Time for Reflection on the Progress Toward a Cure
- Profiles in Pulmonary Hypertension
In a Remarkably Short Time, Vallerie McLaughlin, MD, Joins a Select Group of Investigators Blazing a Trail in PH Research
- Advances in Pulmonary Hypertension CME Section
- The Metabolic Syndrome and Cardiac Function
The metabolic syndrome includes obesity, insulin resistance, dyslipidemia, and type 2 diabetes mellitus. It increases the risk of developing cardiovascular diseases, including heart failure.
- National Heart Lung and Blood Institute Hopkins Specialized Center in Clinical Oriented Research (SCCOR): Molecular Determinants of Pulmonary Arterial Hypertension
Recently, the National Heart, Lung, and Blood Institute awarded 2 Specialized Centers of Clinically Oriented Research (SCCOR) program grants in pulmonary hypertension. The SCCOR program requires clinical and basic scientists with a broad range of skills to work together on a unified theme, with special emphasis on clinically relevant research.
- Specialized Center in Clinical Oriented Research (SCCOR) Update: Mechanisms and Treatment of Lung Vascular Disease in Infants and Children
In contrast to lung branching morphogenesis, studies of the mechanisms that regulate lung vascular development and that link capillary growth with alveolarization are relatively recent and limited in scope.
- Getting More From Right Heart Catheterization: A Focus on the Right Ventricle
The primary challenge in the care of the patient with advanced pulmonary hypertension (PH) is right ventricular dysfunction with concomitant right heart failure, which is the most important cause of mortality in the disease.
- Animal Models of Human Severe PAH
Based on differences in clinical presentation, diagnostic findings, and response to treatment, human pulmonary hypertension (PH) has been subdivided into 5 categories.
- Self-Assessment Examination
- Pulmonary Hypertension Roundtable
PHA Scientific Sessions Provide a Great Window Into Treatment Breakthroughs While Inspiring Physicians and Patients Alike
- International Corner
Connective Tissue Disease-Associated Pulmonary Hypertension
